Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment

Condition:   Asthma
Interventions:   Drug: QAW039;   Drug: QAW039;   Drug: Placebo
Sponsor:   Novartis Pharmaceuticals
Not yet recruiting – verified July 2015

View full post on asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.